PHARMGEONETIC EFFECT ON PLASMA CONCENTRATION OF TAMOXIFEN THROUGH HPLC IN FEMALE SUBJECTS OF PAKISTAN

Publisher:
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
Publication Type:
Journal Article
Citation:
WORLD JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2016, 5 (3), pp. 1799 - 1808 (9)
Issue Date:
2016-02-29
Full metadata record
Files in This Item:
Filename Description Size
article_wjpps_1485753317.pdfPublished Version667.87 kB
Adobe PDF
The pharmgeonetic and pharmenzymonetic factors alter plasma concentration of a drug achieved after the same dosage regimen in various individuals. Breast cancer being second most killing disease holds tamoxifen as a treatment of choice for years for woman. Its plasma concentration determines therapeutic output for that eight healthy female volunteers were selected from Pakistan region and single dose 20mg of Tamoxifen was given. After collection of blood samples at known intervals, plasma concentration was determined by high performance liquid chromatography. The maximum plasma concentration was 32.54±0.44 ng/mL at time 6 hours after administration. Mean ± SE initial tamoxifen concentration was 4.8 ± 0.41 ng/mL and at 24 hours it was recorded as 7.4 ± 2.06 ng/mL respectively. The concentration obtained was lesser than literature values proving geographical region dependent decrease altering therapeutic outcome and therapeutic drug monitoring is essential for breast cancer patients in short and for every ailment in long term.
Please use this identifier to cite or link to this item: